10.1128/aem.01959-23 52 QuinziiC
Ascidian is eligible for up to $1.9 billion in payments, including prepayments, development and commercialization milestone payments, and tiered royalties based on global sales
Muscle retention and gain: Even in a caloric deficit, patients hold muscle and often build some new muscle simultaneously
In November 2023, the Food and Drug Administration approved Zepbound, already available as diabetes medication Mounjaro, as a treatment for weight loss
When you consume carbohydrates, GLP-1 boosts the amount of insulin the body makes in order to bring your blood sugar back to normal, says Dr
#EmployeeBenefits #HealthcareStrategy #SelfFunded #PBM #PharmacyBenefits #GLP1 To view or add a comment, sign in More Relevant Posts I wrote about how PBM reform paved the way for more aggressive, structural legislative reforms that would break up Big Medicine middlemen including the "Big Three" PBMs' parent insurance conglomerates and wholesale drug distributors that drive healthcare costs up, quality down, and independent providers out of business